Africa: As Funding Cuts Bite, South Africa’s AIDS Conference Pushes for Inclusive, Innovative HIV Strategies

Africa: As Funding Cuts Bite, South Africa’s AIDS Conference Pushes for Inclusive, Innovative HIV Strategies

Johannesburg — The 12th South African AIDS Conference opened this week at Emperor’s Palace in Gauteng, South Africa, as pressure mounted on health systems in the host country and the region. The conference, which runs from September 8-11, drew about 1,400 delegates under the theme Unite for Change, Empower Communities and Redefine Priorities for HIV/AIDS….

Read More
Africa: A New HIV Prevention Jab Could End Aids – Unless Secrecy and Greed Get in the Way

Nigeria: Breastfeeding Week 2025 – Empowering African Women By Integrating HIV Prevention Into the First Bonds of Life

Prudence Nonkululeko Ngwenya and Toyin Saraki (Guest writers) During the recently commemorated Pan-African Women’s Day (PAWD), we were reminded of the enduring legacy, resilience, and leadership of African women. However, as we celebrated, we also confronted a lingering truth: far too many pregnant and breastfeeding women in Africa are still left behind in HIV prevention…

Read More
Africa: A New HIV Prevention Jab Could End Aids – Unless Secrecy and Greed Get in the Way

Africa’s Push for HIV Independence Advances With First Procurement of Locally Made Medicines

Sub-Saharan Africa has taken a cautious but critical step toward greater health self-reliance as locally produced HIV medicines and diagnostic tests begin reaching national programmes – including, for the first time, procurement of African-made treatment for Mozambique. The development marks a milestone for a region that bears nearly 65 per cent of the global HIV…

Read More
Africa: A New HIV Prevention Jab Could End Aids – Unless Secrecy and Greed Get in the Way

Africa: Empowering African Women From the Start – Integrating HIV Prevention Into the First Bonds of Life

Each year, Pan-African Women’s Day (PAWD) reminds us of the enduring legacy, resilience, and leadership of African women. However, as we celebrate, we must also confront a lingering truth: far too many pregnant and breastfeeding women in Africa are still left behind in HIV prevention efforts. Pregnant and breastfeeding women are not merely recipients of…

Read More
Africa: A New HIV Prevention Jab Could End Aids – Unless Secrecy and Greed Get in the Way

Africa Adopts 12-Point Action Plan to Eliminate Mother-to-Child Transmission of HIV, Syphilis, and Hepatitis B By 2030

A call to Action has emerged from a High-Level Ministerial Conference on Triple Elimination of HIV, Syphilis, and Hepatitis B, held in Kampala, Uganda. African Ministers of Health, development partners, and civil society organisations committed to a united front to end vertical transmission of the three infections by the year 2030. At the heart of…

Read More
Africa: A New HIV Prevention Jab Could End Aids – Unless Secrecy and Greed Get in the Way

African Ministers Commit to Eliminate Mother-to-Child Transmission of HIV, Syphilis and Hepatitis B By 2030

Health ministers from African Union (AU) member states, along with development partners and civil society organisations, have called for urgent and coordinated action to eliminate mother-to-child transmission of HIV, syphilis, and hepatitis B by 2030. The call was made at the conclusion of the High-Level Ministerial Conference on Triple Elimination, held in Kampala from July…

Read More
Africa: A New HIV Prevention Jab Could End Aids – Unless Secrecy and Greed Get in the Way

Africa: Health Experts, Officials Convene in Uganda for HIV, Hepatitis B, Syphilis Elimination Across Africa

Kampala, Uganda — Health experts, policymakers, and researchers on Monday began a three-day meeting in Kampala, the Ugandan capital, to accelerate the elimination of mother-to-child transmission of HIV, syphilis, and hepatitis B across Africa. The event, held under the theme “Unifying Actions, Transforming Futures: Achieving Triple Elimination in Africa by 2030,” is dubbed as Africa’s…

Read More
Africa: Momentum Builds For Long-Acting HIV Solutions As IAS 2025 Spotlights Scientific Progress, Funding Challenges And Leaders’ Calls To Action

Africa: Momentum Builds For Long-Acting HIV Solutions As IAS 2025 Spotlights Scientific Progress, Funding Challenges And Leaders’ Calls To Action

New WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly oral pill MK-8527 advances to Phase 3 trials in Africa  14 July 2025 (Kigali, Rwanda)  – IAS 2025, the 13th IAS Conference on HIV Science, opened today with a call to accelerate…

Read More